The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

Vimkunya™ (chikungunya vaccine, recombinant) is now available in the US for the prevention of disease caused by chikungunya ...

Vimkunya, on the other hand, is a virus-like particle (VLP) vaccine, meaning it works by mimicking the chikungunya virus to ...

In the Virus-Like Particle Translational Oncology Laboratory, Qizhi Cathy Yao, M.D., Ph.D. is developing non-infectious HIV virus-like particles (VLPs) as candidate HIV mucosal vaccines for both ...

The formation of VLP is depicted in Figure 1. Figure 1. The formation of a virus-like particle (VLP). Image Credit: Sino Biological Inc. To enable targeted drug research, Sino Biological has ...

The European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine approved in Europe for individuals as young as 12 years old. Vimkunya is a ...